登录  注册
神经病学术中心首页 > 期刊 > 全球精选文摘

神经病学术中心

抗血小板药物预防先兆子痫:一项对单个患者资料的荟萃分析

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

来源:国际医学期刊 发布时间:2012-5-8
作者:Askie LM, for the PARIS Collaborative Group
期刊: LANCET NEUROL2012年1月期卷

Abstract

Background:

Pre-eclampsia is a major cause of mortality and morbidity during pregnancy and childbirth. Antiplatelet agents, especially low-dose aspirin, might prevent or delay pre-eclampsia, and thereby improve outcome. Our aim was to assess the use of antiplatelet agents for the primary prevention of pre-eclampsia, and to explore which women are likely to benefit most.

Methods:

We did a meta-analysis of individual patient data from 32 217 women, and their 32 819 babies, recruited to 31 randomised trials of pre-eclampsia primary prevention.

Findings:

For women assigned to receive antiplatelet agents rather than control, the relative risk of developing pre-eclampsia was 0·90 (95% CI 0·84–0·97), of delivering before 34 weeks was 0·90 (0·83–0·98), and of having a pregnancy with a serious adverse outcome was 0·90 (0·85–0·96). Antiplatelet agents had no significant effect on the risk of death of the fetus or baby, having a small for gestational age infant, or bleeding events for either the women or their babies. No particular subgroup of women was substantially more or less likely to benefit from antiplatelet agents than any other.

Interpretation:

Antiplatelet agents during pregnancy are associated with moderate but consistent reductions in the relative risk of pre-eclampsia, of birth before 34 weeks' gestation, and of having a pregnancy with a serious adverse outcome.

顶一下(1

发表评论

学科影响因子排名more

 会议回顾 more

  • 第27届欧洲神经心理药理学学院大会...

  • 《阿尔茨海默病与痴呆(中文版)》启...

  • 深化卒中防治 践行规范、推广、指导

 热门病例 more

 热门指南  more

Elsevier中国网站
爱唯医学网
爱思唯尔科技部
NursingChina
柳叶刀中文版
大通医疗决策
医大爱思唯尔
Elsevier医学数据库
CK
Journal Consult
Procedures_CONSULT
ClinicalPharmacologyLogo
3D Interact Anatomy
Mosby’s Nursing Consult
NursingChina
Science Direct